Skip Navigation

BELLUS Health

  • News
  • Events & Presentations
  • Visit us on Twitter
  • Visit us on LinkedIn
Bellus Health logo
  • EN
  • FR
Bellus Health logo
    • EN
    • FR
  • About Us
    • Our Company
    • Our Team
    • Board of Directors
    • Clinical Advisory Board
    • Contact Us
  • Pipeline
    • Our Pipeline
    • Camlipixant (BLU-5937)
  • Science
    • Role of P2X3
    • Scientific Publications
  • Patients
    • What is Chronic Cough?
    • Clinical Trials
  • Investors & Media
    • Investors Home
    • Press Releases
    • Events & Presentations
    • Financial Reports & Other
      • SEC Filings
      • Other Filings
    • Stock Information
      • Stock Quote & Chart
      • Analyst Coverage
    • Corporate Governance
      • Documents & Charters
      • Management
      • Board of Directors
      • Clinical Advisory Board
      • Committee Composition
    • Investor Resources
      • Investor Contact
      • FAQs
      • Email Alerts
  • Careers
    • Join Our Team
    • Job Opportunities
  • Visit us on Twitter Visit us on LinkedIn

Site Map

  • Home
  • About Us
    • Our Company
    • Our Team
    • Board of Directors
    • Clinical Advisory Board
    • Contact Us
  • Pipeline
    • Our Pipeline
    • Camlipixant (BLU-5937)
  • Science
    • Role of P2X3
    • Scientific
      Publications
  • Patients
    • What is Chronic Cough?
    • Clinical Trials
  • Investors
    & Media
    • Investors Home
    • Press Releases
    • Events & Presentations
    • Financial Reports & Other
      • SEC Filings
      • Other Filings
    • Stock Information
      • Stock Quote & Chart
      • Analyst Coverage
    • Corporate Governance
      • Documents & Charters
      • Management
      • Board of Directors
      • Clinical Advisory Board
      • Committee Composition
    • Investor Resources
      • Investor Contact
      • FAQs
      • Email Alerts
  • Careers
    • Join Our Team
    • Job Opportunities
  • Risk Factors
  • Privacy Notice
  • Legal Disclaimer
  • Site Map
Bellus Health logo

BELLUS Health, Inc.

275 Armand-Frappier Blvd.
Laval, Quebec H7V 4A7
Canada

T 450 680 4500

F 450 680 4501

E info@bellushealth.com

Visit us on Twitter
Visit us on LinkedIn
BELLUS HEALTH IS A DRUG DEVELOPMENT COMPANY AND OUR PRODUCT CANDIDATES ARE NOT YET COMMERCIALIZED. INVESTING IN OUR COMMON SHARES INVOLVES A SIGNIFICANT AMOUNT OF RISK. REFER TO THE ANNUAL INFORMATION FORM IN THE INVESTOR AND MEDIA SECTION OF THIS WEBSITE OR AT WWW.SEDAR.COM FOR A DESCRIPTION OF RISK FACTORS ASSOCIATED WITH OUR BUSINESS.
  • Risk Factors
  • Privacy Notice
  • Legal Disclaimer
  • Site Map

©2023 BELLUS Health Inc. All Rights Reserved.

Schema